Revolution Medicines Inc.

NASDAQ: RVMD · Real-Time Price · USD
36.31
0.29 (0.81%)
At close: Aug 15, 2025, 3:44 PM

Revolution Medicines Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
543.06M 696.15M 161.41M 108.5M
Short-Term Investments
1.75B 1.16B 483.53M 468.56M
Long-Term Investments
n/a n/a 1.74M 1.74M
Other Long-Term Assets
17.57M 10.06M -23.4M -14.49M
Receivables
n/a 1.25M 4.67M 5.93M
Inventory
n/a n/a n/a -12.72M
Other Current Assets
38.33M 25.07M 10.57M n/a
Total Current Assets
2.33B 1.88B 660.18M 577.05M
Property-Plant & Equipment
141.82M 100.01M 73.74M 71.24M
Goodwill & Intangibles
71.28M 72.35M 73.42M 74.48M
Total Long-Term Assets
230.67M 182.42M 151.75M 160.93M
Total Assets
2.56B 2.06B 811.93M 737.99M
Account Payables
54.43M 61.79M 21.31M 14.06M
Deferred Revenue
n/a n/a 4.46M 18.93M
Short-Term Debt
n/a n/a 6.77M 6.21M
Other Current Liabilities
31.36M 51.08M 9.39M 11.65M
Total Current Liabilities
163.91M 143.85M 61.98M 18.93M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
3.86M 7.97M 301K 634K
Total Long-Term Liabilities
129.18M 91.66M 64.76M 116.49M
Total Liabilities
293.1M 235.51M 126.74M 135.42M
Total Debt
135.84M 87.94M 64.2M 66.63M
Common Stock
18K 16K 9K 8K
Retained Earnings
-1.74B -1.14B -701.34M -452.64M
Comprehensive Income
1.32M 544K -1.78M -376K
Shareholders Equity
2.27B 1.83B 685.19M 602.57M
Total Investments
1.75B 1.16B 483.53M 468.56M